Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011–2013

Artesunate is the most effective treatment for severe malaria. However, delayed-onset hemolytic anemia has been observed in ≈20% of travelers who receive artesunate, ≈60% of whom require transfusion. This finding could discourage physicians from using artesunate. We prospectively evaluated a cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Jauréguiberry, Stéphane, Thellier, Marc, Ndour, Papa Alioune, Ader, Flavie, Roussel, Camille, Sonneville, Romain, Mayaux, Julien, Matheron, Sophie, Angoulvant, Adela, Wyplosz, Benjamin, Rapp, Christophe, Pistone, Thierry, Lebrun-Vignes, Bénédicte, Kendjo, Eric, Danis, Martin, Houzé, Sandrine, Bricaire, François, Mazier, Dominique, Buffet, Pierre, Caumes, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412216/
https://www.ncbi.nlm.nih.gov/pubmed/25898007
http://dx.doi.org/10.3201/eid2105.141171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412216/
https://www.ncbi.nlm.nih.gov/pubmed/25898007
http://dx.doi.org/10.3201/eid2105.141171

Ejemplares similares